Implications of TGFβ Signaling and CDK Inhibition for the Treatment of Breast Cancer
TGFβ signaling enacts tumor-suppressive functions in normal cells through promotion of several cell regulatory actions including cell-cycle control and apoptosis. Canonical TGFβ signaling proceeds through phosphorylation of the transcription factor, SMAD3, at the C-terminus of the protein. During on...
Enregistré dans:
Auteurs principaux: | Joseph T. Decker, Jeffrey A. Ma, Lonnie D. Shea, Jacqueline S. Jeruss |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/201ed25b35bb465cbe9f3da4b58fbc5f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway
par: Wang Jian, et autres
Publié: (2020) -
The Role of CDK4 in the Pathogenesis of Pancreatic Cancer
par: Emily Jiggens, et autres
Publié: (2021) -
Downregulation of TGF-β1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/Smad3 signaling
par: Wang,Yanqiu, et autres
Publié: (2018) -
SP-1154, a novel synthetic TGF-β inhibitor, alleviates obesity and hepatic steatosis in high-fat diet-induced mice
par: Kisoo Pahk, et autres
Publié: (2022) -
Sinomenine Relieves Airway Remodeling By Inhibiting Epithelial-Mesenchymal Transition Through Downregulating TGF-β1 and Smad3 Expression In Vitro and In Vivo
par: Hongjuan He, et autres
Publié: (2021)